Serotonin receptor modulation in irritable bowel syndrome: one step forwards and one step backwards.
Whorwell
P J
PJ
Department of Medicine University Hospital of South Manchester, Manchester, UK. peter.whorwell@smuht.nwest.nhs.uk
D000328:Adult; D000368:Aged; D002243:Carbolines / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010147:Pain Measurement; D016032:Randomized Controlled Trials as Topic; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D016896:Treatment Outcome
D002243:Carbolines; D005765:Gastrointestinal Agents; D012702:Serotonin Antagonists; C090840:alosetron